|
|
||||||||
and IL-4-Producing CD4+ and CD8+ T Cells1


* Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329; and
Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322
DNA-based immunizations have been used to determine the patterns of type 1 and type 2 cytokines that can be induced in vivo for Ag-specific CD4+ and CD8+ T cells. IL-4 was used as a signature cytokine for a type 2 T cell response and IFN-
as the signature cytokine for a type 1 response. Gene gun deliveries of secreted Ags were used to bias responses toward type 2 and saline injections of cell-associated Ags to bias responses toward type 1. The studies revealed that gene gun bombardments of DNAs expressing secreted Ags strongly biased responses toward type 2, inducing IL-4-producing CD8+ as well as CD4+ T cells. Saline injections of DNAs expressing cell-associated Ags strongly biased responses toward type 1, inducing IFN-
-producing CD8+ and CD4+ cells. A mixed type 1/type 2 response of IFN-
-producing CD8+ T cells and IL-4-producing CD4+ T cells was found for gene gun deliveries of cell-associated Ags. Saline injections of secreted Ags raised a weakly type 1-biased response characterized by only slightly higher frequencies of IFN-
- than IL-4-producing CD4+ and CD8+ T cells. Studies in B cell knockout and hen egg lysozyme Ig transgenic mice revealed that B cells were required for the generation of IL-4-producing CD8+ T cells.
This article has been cited by other articles:
![]() |
W. Zhang, W. Li, Y. Li, H. Li, B. Wang, F. Wang, Y. Zhu, Z. Jiang, L. Zhong, and M. Li Immune effects against influenza A virus and a novel DNA vaccine with co-expression of haemagglutinin- and neuraminidase-encoding genes J. Med. Microbiol., July 1, 2009; 58(7): 845 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Adeeku, P. Gudapati, Y. Mendez-Fernandez, L. Van Kaer, and M. Boothby Flexibility accompanies commitment of memory CD4 lymphocytes derived from IL-4 locus-activated precursors PNAS, July 8, 2008; 105(27): 9307 - 9312. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-S. Quan, C. Huang, R. W. Compans, and S.-M. Kang Virus-Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Influenza Virus J. Virol., April 1, 2007; 81(7): 3514 - 3524. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cseke, D. W. Wright, S. J. Tollefson, J. E. Johnson, J. E. Crowe Jr., and J. V. Williams Human Metapneumovirus Fusion Protein Vaccines That Are Immunogenic and Protective in Cotton Rats J. Virol., January 15, 2007; 81(2): 698 - 707. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Applequist, E. Rollman, M. D. Wareing, M. Liden, B. Rozell, J. Hinkula, and H.-G. Ljunggren Activation of Innate Immunity, Inflammation, and Potentiation of DNA Vaccination through Mammalian Expression of the TLR5 Agonist Flagellin J. Immunol., September 15, 2005; 175(6): 3882 - 3891. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-W. Lee, A. T. Vella, B. S. Kwon, and M. Croft Enhanced CD4 T Cell Responsiveness in the Absence of 4-1BB J. Immunol., June 1, 2005; 174(11): 6803 - 6808. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Alvarez, G. Harder, R. Fattouh, J. Sun, S. Goncharova, M. R. Stampfli, A. J. Coyle, J. L. Bramson, and M. Jordana Cutaneous Antigen Priming via Gene Gun Leads to Skin-Selective Th2 Immune-Inflammatory Responses J. Immunol., February 1, 2005; 174(3): 1664 - 1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Kang, L. Guo, Q. Yao, I. Skountzou, and R. W. Compans Intranasal Immunization with Inactivated Influenza Virus Enhances Immune Responses to Coadministered Simian-Human Immunodeficiency Virus-Like Particle Antigens J. Virol., September 15, 2004; 78(18): 9624 - 9632. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Oran and H. L. Robinson DNA Vaccines: Influenza Virus Challenge of a Th2/Tc2 Immune Response Results in a Th2/Tc1 Response in the Lung J. Virol., April 15, 2004; 78(8): 4376 - 4380. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |